Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1979 Mar;65(3):411–421. doi: 10.1111/j.1476-5381.1979.tb07845.x

Pharmacological aspects of neuromuscular transmission in the isolated diaphragm of the dystrophic (Rej 129) mouse.

J B Harris, R R Ribchester
PMCID: PMC1668655  PMID: 218667

Abstract

1. Some aspects of the pharmacology of neuromuscular transmission have been studied in the isolated diaphragm of the normal and dystrophic mouse. 2. The effects of (+)-tubocurarine and atropine on the indirectly elicited twitch responses of the dystrophic diaphragm were indistinguishable from normal. 3. Intracellular recording techniques revealed no significant differences between the rise time, time to half decay, frequency and amplitude of miniature endplate potentials (m.e.p.ps) recorded in dystrophic muscle fibres, compared to those recorded in normal muscle fibres. 4. Transmitter null potential, the size of the available store of transmitter, the probability of release of the transmitter, and the characteristics of endplate potentials (e.p.ps) of dystrophic muscle fibres did not differ from normal. 5. The quantum contents of e.p.ps generated in response to nerve stimulation of 0.1 to 100 HZ were consistently larger in dystrophic muscle fibres than in normal muscle fibres, but the differences were not statistically significant under the conditions of the experiment.

Full text

PDF
411

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan W., Gascoigne K., Ludlow J., Smith J. W. A modular system of instruments for simple experiments on skeletal muscle using intracellular microelectrode techniques [proceedings]. Br J Pharmacol. 1977 Sep;61(1):155P–155P. [PMC free article] [PubMed] [Google Scholar]
  2. Andersen P., Etholm B., Gordon G. Presynaptic and post-synaptic inhibition elicited in the cat's dorsal column nuclei by mechanical stimulation of skin. J Physiol. 1970 Sep;210(2):433–455. doi: 10.1113/jphysiol.1970.sp009219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BAKER N., SABAWALA P. B. ABNORMAL PHARMACOLOGICAL RESPONSES OF ISOLATED NERVE-MUSCLE PREPARATIONS FROM MUSCULAR DYSTROPHIC MICE. J Pharmacol Exp Ther. 1963 Aug;141:214–222. [PubMed] [Google Scholar]
  4. BAKER N., WILSON L., OLDENDORF W., BLAHD W. H. Supersensitivity to neostigmine and resistance to d-tubocurarine in mice with hereditary myopathy. Am J Physiol. 1960 May;198:926–930. doi: 10.1152/ajplegacy.1960.198.5.926. [DOI] [PubMed] [Google Scholar]
  5. BARSTAD J. A. Presynaptic effect of the neuro-muscular transmitter. Experientia. 1962 Dec 15;18:579–580. doi: 10.1007/BF02172193. [DOI] [PubMed] [Google Scholar]
  6. Beaulnes A., Bois P., Carle R. Pharmacological reactivity of dystrophic muscle. Can J Physiol Pharmacol. 1966 Mar;44(2):353–366. doi: 10.1139/y66-042. [DOI] [PubMed] [Google Scholar]
  7. Beránek R., Vyskocil F. The action of tubocurarine and atropine on the normal and denervated rat diaphragm. J Physiol. 1967 Jan;188(1):53–66. doi: 10.1113/jphysiol.1967.sp008123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DEL CASTILLO J., ENGBAEK L. The nature of the neuromuscular block produced by magnesium. J Physiol. 1954 May 28;124(2):370–384. doi: 10.1113/jphysiol.1954.sp005114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DEL CASTILLO J., KATZ B. Quantal components of the end-plate potential. J Physiol. 1954 Jun 28;124(3):560–573. doi: 10.1113/jphysiol.1954.sp005129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Douglas W. B., Jr, Baskin R. J. Contractile properties of developing mouse dystrophic muscle. Am J Physiol. 1971 May;220(5):1344–1354. doi: 10.1152/ajplegacy.1971.220.5.1344. [DOI] [PubMed] [Google Scholar]
  11. Elmqvist D., Quastel D. M. A quantitative study of end-plate potentials in isolated human muscle. J Physiol. 1965 Jun;178(3):505–529. doi: 10.1113/jphysiol.1965.sp007639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Harris J. B., Marshall M. W., Wilson P. A physiological study of chick myotubes grown in tissue culture. J Physiol. 1973 Mar;229(3):751–766. doi: 10.1113/jphysiol.1973.sp010165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Harris J. B., Ribchester R. R. Neuromuscular transmission in the isolated diaphragm of the dystrophic mouse (129 ReJ/dy.dy) [proceedings]. J Physiol. 1976 Dec;263(1):118P–119P. [PMC free article] [PubMed] [Google Scholar]
  14. Harris J. B., Ribchester R. R. Neuromuscular transmission is adequate in identified abnormal dystrophic muscle fibres. Nature. 1978 Jan 26;271(5643):362–364. doi: 10.1038/271362a0. [DOI] [PubMed] [Google Scholar]
  15. Harris J. B. The resting membrane potential of fibres of fast and slow twitch muscles in normal and dystrophic mice. J Neurol Sci. 1971 Jan;12(1):45–52. doi: 10.1016/0022-510x(71)90250-4. [DOI] [PubMed] [Google Scholar]
  16. Harris J. B., Wilson P. Mechanical properties of dystrophic mouse muscle. J Neurol Neurosurg Psychiatry. 1971 Oct;34(5):512–520. doi: 10.1136/jnnp.34.5.512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hubbard J. I., Wilson D. F. Neuromuscular transmission in a mammalian preparation in the absence of blocking drugs and the effect of D-tubocurarine. J Physiol. 1973 Jan;228(2):307–325. doi: 10.1113/jphysiol.1973.sp010088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. KRNJEVIC K., MILEDI R. Presynaptic failure of neuromuscular propagation in rats. J Physiol. 1959 Dec;149:1–22. doi: 10.1113/jphysiol.1959.sp006321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Karmali R. A., Horrobin D. F. Abnormalities of thymus growth in dystrophic mice. Nature. 1976 Oct 21;263(5579):684–685. doi: 10.1038/263684a0. [DOI] [PubMed] [Google Scholar]
  20. Katz B., Miledi R. The effect of atropine on acetylcholine action at the neuromuscular junction. Proc R Soc Lond B Biol Sci. 1973 Nov 27;184(1075):221–226. doi: 10.1098/rspb.1973.0046. [DOI] [PubMed] [Google Scholar]
  21. Kelly S. S. The effect of age on neuromuscular transmission. J Physiol. 1978 Jan;274:51–62. doi: 10.1113/jphysiol.1978.sp012133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. LILEY A. W. An investigation of spontaneous activity at the neuromuscular junction of the rat. J Physiol. 1956 Jun 28;132(3):650–666. doi: 10.1113/jphysiol.1956.sp005555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Law P. K., Atwood H. L., McComas A. J. Functional denervation in the soleus muscle of dystrophic mice. Exp Neurol. 1976 May;51(2):434–443. doi: 10.1016/0014-4886(76)90267-3. [DOI] [PubMed] [Google Scholar]
  24. Law P. K., Atwood H. L. Nonequivalence of surgical and natural denervation in dystrophic mouse muscles. Exp Neurol. 1972 Feb;34(2):200–209. doi: 10.1016/0014-4886(72)90167-7. [DOI] [PubMed] [Google Scholar]
  25. MARTIN A. R. A further study of the statistical composition on the end-plate potential. J Physiol. 1955 Oct 28;130(1):114–122. doi: 10.1113/jphysiol.1955.sp005397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. McComas A. J., Mrozek K. Denervated muscle fibres in hereditary mouse dystrophy. J Neurol Neurosurg Psychiatry. 1967 Dec;30(6):526–530. doi: 10.1136/jnnp.30.6.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Michelson A. M., Russell E. S., Harman P. J. Dystrophia Muscularis: A HEREDITARY PRIMARY MYOPATHY IN THE HOUSE MOUSE. Proc Natl Acad Sci U S A. 1955 Dec 15;41(12):1079–1084. doi: 10.1073/pnas.41.12.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Miyamoto M. D. Binomial analysis of quantal transmitter release at glycerol treated frog neuromuscular junctions. J Physiol. 1975 Aug;250(1):121–142. doi: 10.1113/jphysiol.1975.sp011045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Purves D., Sakmann B. The effect of contractile activity on fibrillation and extrajunctional acetylcholine-sensitivity in rat muscle maintained in organ culture. J Physiol. 1974 Feb;237(1):157–182. doi: 10.1113/jphysiol.1974.sp010475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rowe R. W., Goldspink G. Muscle fibre growth in five different muscles in both sexes of mice. II. Dystrophic mice. J Anat. 1969 May;104(Pt 3):531–538. [PMC free article] [PubMed] [Google Scholar]
  31. SANDOW A., BRUST M. Contractility of dystrophic mouse muscle. Am J Physiol. 1958 Sep;194(3):557–563. doi: 10.1152/ajplegacy.1958.194.3.557. [DOI] [PubMed] [Google Scholar]
  32. Taylor R. G., Fowler W. M., Jr, Mason D. T., Spann J. F., Jr Contractile properties of skeletal muscle in dystrophic mice. Arch Phys Med Rehabil. 1971 Nov;52(11):511–515. [PubMed] [Google Scholar]
  33. WEST W. T., MURPHY E. D. Histopathology of hereditary, progressive muscular dystrophy in inbred strain 129 mice. Anat Rec. 1960 Jul;137:279–295. doi: 10.1002/ar.1091370306. [DOI] [PubMed] [Google Scholar]
  34. Waud D. R., Waud B. E. In vitro measurement of margin of safety of neuromuscular transmission. Am J Physiol. 1975 Dec;229(6):1632–1634. doi: 10.1152/ajplegacy.1975.229.6.1632. [DOI] [PubMed] [Google Scholar]
  35. Wilson D. F. Estimates of quantal-release and binomial statistical-release parameters at rat neuromuscular junction. Am J Physiol. 1977 Nov;233(5):C157–C163. doi: 10.1152/ajpcell.1977.233.5.C157. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES